ADRB2, adrenoceptor beta 2, 154

N. diseases: 53; N. variants: 1
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Biomarker phenotype CTD_human Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats. 7902979 1993
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Therapeutic phenotype CTD_human Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats. 7902979 1993
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Therapeutic phenotype CTD_human Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. 8102213 1993
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Biomarker phenotype CTD_human Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. 8102213 1993
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Biomarker phenotype CTD_human Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. 190674 1977
CUI: C0234376
Disease: Action Tremor
Action Tremor 		0.300 Therapeutic phenotype CTD_human Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. 190674 1977
CUI: C0001849
Disease: AIDS Dementia Complex
AIDS Dementia Complex 		0.300 Biomarker disease CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0004096
Disease: Asthma
Asthma 		0.500 Biomarker disease CTD_human
CUI: C0004352
Disease: Autistic Disorder
Autistic Disorder 		0.310 Biomarker disease CTD_human The objective of this study was to determine whether alleles in ADRB2 are associated with diagnosis of autism in the Autism Genetic Resource Exchange (AGRE) population. 17199132 2007
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder 		0.320 Biomarker disease PSYGENET However, as the ADRB2 gene product directly interacts with the CACNA1C gene product, and is known to be implicated in BD susceptibility, we conclude that further exploration of the relationships between ADRB2 and BD needs to be undertaken. 22628130 2012
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies 		0.310 Biomarker group CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary 		0.300 Biomarker group CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0007193
Disease: Cardiomyopathy, Dilated
Cardiomyopathy, Dilated 		0.510 Biomarker group CTD_human Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. 11986409 2002
CUI: C1449563
Disease: Cardiomyopathy, Familial Idiopathic
Cardiomyopathy, Familial Idiopathic 		0.300 Biomarker disease CTD_human Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. 11986409 2002
CUI: C1623038
Disease: Cirrhosis
Cirrhosis 		0.330 Biomarker disease CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Therapeutic phenotype CTD_human Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. 8102213 1993
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Biomarker phenotype CTD_human Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. 190674 1977
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Therapeutic phenotype CTD_human Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. 190674 1977
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Therapeutic phenotype CTD_human Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats. 7902979 1993
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Biomarker phenotype CTD_human Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats. 7902979 1993
CUI: C0234374
Disease: Coarse Tremor
Coarse Tremor 		0.300 Biomarker phenotype CTD_human Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. 8102213 1993